Rifapentine is a cyclopentyl rifamycin antimycobacterial agent indicated for the treatment of active pulmonary tuberculosis and late tuberculosis infection.

HealthDay News — Clover Hill Dairy is recalling all of its brand cheese over possible Listeria contamination tied to a ...

In patients with 1 prior line of systemic therapy, the IB6-directed ADC showed favorable trends in both overall survival and progression free survival vs docetaxel.

Transitioning from accelerated to traditional status, the FDA's decision expands eligibility for the first solid-tumor engineered T cell therapy to include adolescents aged 12 and older.

Living guideline presents pharmacologic treatments that are recommended with lifestyle modifications for weight management.

Backed by a phase 3 trial of over 40,000 participants, the investigational trivalent mRNA-1010 vaccine met superiority criteria against a standard-dose comparator with a manageable safety profile.

Supported by the phase 3 NIMBLE trial, the novel siRNA met its primary endpoint, demonstrating significant 24-week improvements in MG-ADL scores.

DT120 ODT significantly improved MADRS scores at week 6 compared with placebo (-13.3 vs. -5.2; P .0001). Topline data were announced from a phase 3 trial evaluating DT120 (lysergide) orally ...

Both Tal-DP and Tal-D yielded longer progression-free survival than DPd in those who had received at least one line of therapy. HealthDay News — Among patients with relapsed or refractory multiple ...

Metastatic androgen pathway modulation-naïve or -sensitive prostate cancer was previously referred to as metastatic hormone-sensitive prostate cancer.

Credit: Bayer. Two phase 3 trials supported the approval of gadoquatrane, a novel macrocyclic GBCA for imaging CNS and non-CNS pathologies. The novel macrocyclic contrast agent delivers high-quality ...